256 related articles for article (PubMed ID: 30985083)
1. Repurposing fed-batch media and feeds for highly productive CHO perfusion processes.
Kuiper M; Spencer C; Fäldt E; Vuillemez A; Holmes W; Samuelsson T; Gruber D; Castan A
Biotechnol Prog; 2019 Jul; 35(4):e2821. PubMed ID: 30985083
[TBL] [Abstract][Full Text] [Related]
2. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
Xu S; Gavin J; Jiang R; Chen H
Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
[TBL] [Abstract][Full Text] [Related]
3. Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.
Hiller GW; Ovalle AM; Gagnon MP; Curran ML; Wang W
Biotechnol Bioeng; 2017 Jul; 114(7):1438-1447. PubMed ID: 28128436
[TBL] [Abstract][Full Text] [Related]
4. Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.
Lin H; Leighty RW; Godfrey S; Wang SB
Biotechnol Prog; 2017 Jul; 33(4):891-901. PubMed ID: 28371394
[TBL] [Abstract][Full Text] [Related]
5. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures.
Yongky A; Xu J; Tian J; Oliveira C; Zhao J; McFarland K; Borys MC; Li ZJ
MAbs; 2019; 11(8):1502-1514. PubMed ID: 31379298
[TBL] [Abstract][Full Text] [Related]
6. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
7. Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.
Walther J; Lu J; Hollenbach M; Yu M; Hwang C; McLarty J; Brower K
Biotechnol J; 2019 Feb; 14(2):e1700733. PubMed ID: 29851298
[TBL] [Abstract][Full Text] [Related]
8. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.
Särnlund S; Jiang Y; Chotteau V
Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903
[TBL] [Abstract][Full Text] [Related]
9. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
10. The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures.
Qin J; Wu X; Xia Z; Huang Z; Zhang Y; Wang Y; Fu Q; Zheng C
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1217-1229. PubMed ID: 30554388
[TBL] [Abstract][Full Text] [Related]
11. Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology.
Stepper L; Filser FA; Fischer S; Schaub J; Gorr I; Voges R
Bioprocess Biosyst Eng; 2020 Aug; 43(8):1431-1443. PubMed ID: 32266469
[TBL] [Abstract][Full Text] [Related]
12. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of the sodium-potassium ratio as a lever for controlling cell growth and improving cell specific productivity in perfusion CHO cell cultures.
Wang SB; Lee-Goldman A; Ravikrishnan J; Zheng L; Lin H
Biotechnol Bioeng; 2018 Apr; 115(4):921-931. PubMed ID: 29278412
[TBL] [Abstract][Full Text] [Related]
14. Engineering death resistance in CHO cells for improved perfusion culture.
MacDonald MA; Nöbel M; Martínez VS; Baker K; Shave E; Gray PP; Mahler S; Munro T; Nielsen LK; Marcellin E
MAbs; 2022; 14(1):2083465. PubMed ID: 35737825
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for Comparison of Productivity Between Fed-Batch and Perfusion Processes.
Bausch M; Schultheiss C; Sieck JB
Biotechnol J; 2019 Feb; 14(2):e1700721. PubMed ID: 30024096
[TBL] [Abstract][Full Text] [Related]
16. Shift to high-intensity, low-volume perfusion cell culture enabling a continuous, integrated bioprocess.
Gagnon M; Nagre S; Wang W; Hiller GW
Biotechnol Prog; 2018 Nov; 34(6):1472-1481. PubMed ID: 30298995
[TBL] [Abstract][Full Text] [Related]
17. Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.
Xiang S; Zhang J; Yu L; Tian J; Tang W; Tang H; Xu K; Wang X; Cui Y; Ren K; Cao W; Su Y; Zhou W
Biotechnol Bioeng; 2024 Feb; 121(2):696-709. PubMed ID: 37994547
[TBL] [Abstract][Full Text] [Related]
18. Hydrocyclones as cell retention device for CHO perfusion processes in single-use bioreactors.
Bettinardi IW; Castan A; Medronho RA; Castilho LR
Biotechnol Bioeng; 2020 Jul; 117(7):1915-1928. PubMed ID: 32181883
[TBL] [Abstract][Full Text] [Related]
19. Screening of Media Supplements for High-Performance Perfusion Cultures by Design of Experiment.
Mayrhofer P; Kunert R
Methods Mol Biol; 2020; 2095():27-39. PubMed ID: 31858461
[TBL] [Abstract][Full Text] [Related]
20. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
